Xu, Yiguan <br/><br/>
Inhibition of neointimal hyperplasia in rats treated with atorvastatin after carotid artery injury may be mainly associated with down-regulation of survivin and Fas expression.  [electronic resource] 

 -  Pharmaceutical biology  Sep 2014 
 - 1196-203 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1744-5116 
<br/><br/><label>Standard No.: </label>10.3109/13880209.2014.884605  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Atorvastatin<br/>Carotid Artery Injuries--drug therapy<br/>Disease Models, Animal<br/>Down-Regulation--drug effects<br/>Enzyme-Linked Immunosorbent Assay<br/>Heptanoic Acids--pharmacology<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Hyperplasia--prevention & control<br/>In Situ Nick-End Labeling<br/>Male<br/>Microtubule-Associated Proteins--blood<br/>Muscle, Smooth, Vascular--cytology<br/>Neointima--prevention & control<br/>Pyrroles--pharmacology<br/>Rats<br/>Survivin<br/>fas Receptor--blood